- Home
- TWLO vs ZTS Comparison
TWLO vs ZTS Comparison
Compare TWLO & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWLO | ZTS |
|---|---|---|
| Founded | 2008 | 1952 |
| Country | United States | United States |
| Employees | 5587 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 31.2B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | TWLO | ZTS |
|---|---|---|
| Price | $187.35 | $81.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 12 |
| Target Price | $151.54 | ★ $154.18 |
| AVG Volume (30 Days) | 2.8M | ★ 7.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $9,467,000,000.00 |
| Revenue This Year | $14.44 | $5.63 |
| Revenue Next Year | $8.21 | $4.77 |
| P/E Ratio | $526.76 | ★ $56.30 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $91.84 | $73.82 |
| 52 Week High | $203.71 | $172.23 |
Technical Indicators
Market Signals| Indicator | TWLO | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 28.89 |
| Support Level | $117.98 | $73.82 |
| Resistance Level | N/A | $129.32 |
| Average True Range (ATR) | 7.94 | 3.79 |
| MACD | -2.54 | -0.25 |
| Stochastic Oscillator | 22.14 | 18.07 |
Price Performance
Historical ComparisonAbout TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.